Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A patient with acquired haemophilia A and pemphigus.
Halbertsma FJ, van der Linden PW, Mauser-Bunschoten EP. Halbertsma FJ, et al. Among authors: van der linden pw. Neth J Med. 1998 May;52(5):190-2. doi: 10.1016/s0300-2977(98)00024-2. Neth J Med. 1998. PMID: 9652158
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MM, Goede-Bolder AD, Leebeek FW, van der Meer J, van Marwijk Kooij GM, van der Linden PW; Recombinant Factor VIIa Data Collection Group. Mauser-Bunschoten EP, et al. Among authors: van der meer j, van der linden pw, van marwijk kooij gm. Haemophilia. 2002 Sep;8(5):649-56. doi: 10.1046/j.1365-2516.2002.00667.x. Haemophilia. 2002. PMID: 12199674
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.
Mauser-Bunschoten EP, Kleine Budde I, Lopaciuk S, Koopman MM, Van Der Meer FJ, Novàkovà IR, Ypma P, Van Der Linden PW, Windyga J, Strengers PF. Mauser-Bunschoten EP, et al. Among authors: van der meer fj, van der linden pw. Haemophilia. 2011 May;17(3):439-45. doi: 10.1111/j.1365-2516.2010.02453.x. Epub 2011 Mar 1. Haemophilia. 2011. PMID: 21362109 Clinical Trial.
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Among authors: van der linden pw, van der bom jg. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
39 results